Tag: Motley Fool

The Environmental Group Ltd (ASX: EGL) share price is rocketing today, up 38% at time of writing.

Below, we take a look at the results from the facility service and environmental solutions company’s commercial water treatment trial that looks to be driving ASX investor interest.

What commercial water trial results were announced?

The Environmental Group share price is surging after the company reported positive results from its commercial PFAS water trial with Reclaim Waste.

PFAS, according to the release, stands for per- and poly-fluoroalkyl substances. The manmade chemicals “are very persistent in the environment and in the human body meaning they don’t break down and can accumulate over time”.

The trial, using the Environmental Group’s foam fractionation technology, was conducted across a number of commercial waste streams and liquid waste types polluted with PFAS at different concentrations.

The company reported it had successfully separated and removed the PFAS to “below detection levels” in every high-volume, low concentrate trial. Additionally, it was able to separate and remove 99.4% of PFAS from its first processing run on the highest concentration trials.

Commenting on the trial results, the Environmental Group’s CEO, Jason Dixon, said:

By running various waste streams at different concentrations it has given us great confidence that the technology has the ability to separate PFAS for destruction across a wide range of liquid waste types covering the majority of the market for PFAS removal.

The trial plant can treat some 50,000 litres per day. It’s operating at Reclaim Waste’s site in Victoria.

In other news that could be providing a tailwind for the Environmental Group share price today, the company announced it has received firm commitments to raise $4.75 million (before costs) through a share placement.

The Group expects to issue some 27.1 million shares at 17.5 cents per share “to advance commercialisation and support other business development opportunities”.

Environmental Group share price snapshot

The Environmental Group share price has been a stellar performer this year, up 700% since 4 January. By comparison, the All Ordinaries Index (ASX: XAO) has gained 11% year-to-date.

Over the past month, shares in the Environmental Group have gained 41%.

The post Up 700% this year, what’s sending the Environmental Group (ASX:EGL) share price 38% higher today? appeared first on The Motley Fool Australia.

More reading

• Why is the ETFS Hydrogen ETF (ASX:HGEN) share price climbing today?
• Top brokers name 3 ASX shares to buy today
• What’s with the Cettire (ASX:CTT) share price today, up 9%?
• Orthocell (ASX:OCC) share price surges 13% on study success
• Survey reveals surprising crypto swing as Aussie housing bubble fears grow

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3oAKrBe

It has been a disappointing past month for the ETFS Hydrogen ETF (ASX: HGEN) share price. However, today has bucked the trend as the hydrogen-focused exchange-traded fund swings to the upside.

In afternoon trade, the clean energy ETF is fetching a price of $11.85, representing an increase of 3.04% from its previous close. Despite the gain, the fund remains 15% below its 52-week high, which was set on 15 November 2021.

Shares in the ASX-listed Hydrogen ETF are rising in value today as a string of notable companies announce further hydrogen ambitions.

Industry titans dipping their toes in hydrogen

The green revolution has been relentless in attempting to upend traditional energy companies. As onlookers become more anxious about the world’s overreliance on fossil fuels, a swathe of more renewable and/or emission-free alternatives have gained traction.

More recently, hydrogen has been held to a high standard as an emission-free replacement to carbon-producing energy sources. For instance, Fortescue Metals Group Limited (ASX: FMG) founder Andrew ‘Twiggy’ Forrest has been advocating for hydrogen.

The company’s subsidiary, Fortescue Fortescue Industries aims to produce 15 million tonnes of water-derived fuel by 2030. Though, investors of the Hydrogen ETF are likely looking at the latest accomplices to join the fray with eager eyes.

Today, the hydrogen industry gained two major energy companies as participants in the hydrogen industry. While the companies haven’t announced a complete upheaval of their fossil fuel foundations, they have indicated — at a minimum — interest in hydrogen energy.

The companies in question are AGL Energy Ltd (ASX: AGL) and Royal Dutch Shell (LSE: RDSA) Firstly, Shell has entered into a joint venture with BlueScope Steel Limited (ASX: BSL) to develop hydrogen projects at the Port Kembla Steelworks. Similarly, AGL has partnered with Fortescue Future Industries to explore the development of a hydrogen hub in the Hunter Valley.

Certainly, these announcements show a genuine interest from energy giants in testing the hydrogen waters. As such, investors of the Hydrogen ETF have likely gained a heightened conviction for hydrogen’s involvement in the future of energy.

How has the Hydrogen ETF performed?

Since listing on 7 October 2021, the ETFS Hydrogen ETF share price has rallied 17.2%. Interestingly, while the ETF is listed on the ASX, it does not contain any Australian companies. Instead, its constituents are predominantly based in the United States. However, the fund’s lack of Aussie companies has not held it back from outperforming the ASX.

The post Why is the ETFS Hydrogen ETF (ASX:HGEN) share price climbing today? appeared first on The Motley Fool Australia.

More reading

• Why has the ETFs Hydrogen ETF (ASX:HGEN) leapt almost 20% in a month?

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3GpNFhm

Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.

Three ASX shares brokers have named as buys this week are listed below. Here’s why they are bullish on them:

APM Human Services International Ltd (ASX: APM)

According to a note out of Goldman Sachs, its analysts have initiated coverage on this health and human services provider’s shares with a buy rating and $3.60 price target. Goldman notes that APM’s revenue is backed by long-term government procurement contracts, with a focus on employment, disability, and allied health services. It also sees strong organic growth opportunities thanks to its ~$2.5 billion per annum revenue tender pipeline and its scaling into the $30 billion per annum NDIS and growing aged care sector. The APM share price is trading at $2.73 today.

Bank of Queensland Limited (ASX: BOQ)

A note out of Macquarie reveals that its analysts have retained their outperform rating and $10.00 price target on this regional bank’s shares. Macquarie was pleased with the bank’s trading update at its annual general meeting and particularly its guidance for positive jaws in FY 2022. It also feels that Bank of Queensland is managing margin pressures well in comparison to some of its peers. The Bank of Queensland share price is fetching $7.96 on Wednesday.

Newcrest Mining Ltd (ASX: NCM)

Analysts at Morgans have retained their add rating but trimmed their price target on this gold miner’s shares to $27.18. Morgans notes that Newcrest recently published studies outlining medium term development plans for its major assets. While the broker acknowledges that a lot of work needs to be done across Newcrest’s portfolio, it remains positive on the investment opportunity. It also sees potential for much greater value at Telfer/Havieron and Brucejack than currently modelled. The Newcrest share price is trading at $23.51 today.

The post Top brokers name 3 ASX shares to buy today appeared first on The Motley Fool Australia.

More reading

• Why Bank of Queensland, Imugene, Webjet, and Zip shares are pushing higher
• Why the Bank of Queensland (ASX:BOQ) share price is racing 5% higher today
• ASX 200 (ASX:XJO) midday update: Zip update impresses, BOQ rises
• Bank of Queensland (ASX:BOQ) share price on watch amid FY22 guidance update
• Why the Bank of Queensland (ASX:BOQ) share price hit reverse in November?

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3lLaAf4

The Cettire Ltd (ASX: CTT) share price is clawing back its heavy losses realised at the beginning of December. This comes despite no new announcements from the company since its annual general meeting (AGM) last month.

During mid-afternoon trade, the online luxury goods retailer’s shares are changing hands for $3.46, up 9.15%. It’s worth noting that despite today’s strong rise, its shares are down almost 10% since last week.

What’s driving Cettire shares higher?

While the rebound could be attributed to the Cettire share price being oversold recently, it appears investors remain optimistic about the company’s opportunities.

With Christmas around the corner, the retail industry is looking to cash in on the difficult year consumers had to endure. Cashed-up families are expected to splurge big for the festive season, and Cettire is in the hot seat.

An FY22 trading update provided by the company indicated its growth momentum had continued with triple-digit increases across key metrics.

As such, for the first four months of the fiscal year, gross revenue soared 184% year-on-year. Sales revenue jumped 172% over the same period on the back of the company’s marketing initiatives and customer acquisition investment.

Cettire noted that, as a result, it is experiencing strong traffic growth of 379% compared to the previous year. Management is aiming to improve the conversion rates to maximise revenue potential.

The active customer base stands around 158,000, which represents a 220% uplift year-on-year.

Cettire share price snapshot

Over the past 12 months, the Cettire share price has accelerated by almost 600%, with year-to-date up an astonishing 630%. The retail industry has been a big winner from COVID-19, with the S&P/ASX 200 Consumer Discretionary Index (ASX: XDJ) roaring 25% higher in 2021.

Based on today’s price, Cettire presides a market capitalisation of around $1.31 billion, with approximately 381.24 million shares on issue.

The post What’s with the Cettire (ASX:CTT) share price today, up 9%? appeared first on The Motley Fool Australia.

More reading

• 2 high-growth ASX shares profiting from the e-commerce boom
• Cettire (ASX:CTT) share price struggles despite 180% revenue growth
• The Cettire (ASX:CTT) share price is soaring 7% to all-time highs. What’s happening?

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Cettire Limited. The Motley Fool Australia has recommended Cettire Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3EyUDA4

The Orthocell Ltd (ASX: OCC) share price is soaring today following news of clinical study success.

At the time of writing, the Orthocell share price is trading hands at 58 cents, up 12.62%.

Orthocell is developing new medical devices and cellular therapies to help people recover from injury.

Why is the share price surging?

It appears investors are responding to positive results from a clinical trial into the use of one of Orthocell’s lead products, OrthoATI.

In today’s release, Orthocell said its data confirmed this product could safely reduce pain in patients suffering from rotator cuff tears. OrthoATI is more effective than steroid injections for treating this injury, according to the company.

Orthocell now plans to speed up its commercialisation plans for OrthoATI in the United States, including conducting a study in front of the Food and Drug Administration.

Orthocell told the market today it believed it could use its OrthoATI treatment to help 480,000 patients per year in the US alone. The company sees this as a US$4 to $5 billion market opportunity (AU $5.6 to $7 billion).

Management commentary

Orthocell managing director Paul Anderson welcomed the news, saying it was an important milestone. He added:

We are absolutely delighted with the study results for this challenging and debilitating condition which clearly demonstrates that OrthoATI is more effective than steroid injection for treatment of rotator cuff tendinopathy with intrasubstance tendon tear.

We are now in a very strong position to progress our US commercialisation strategy to deliver the first injectable cell therapy in orthopaedics that truly addresses the cause of degeneration and returns patients to full use of their chronically damaged tendons.

Orthocell share price snapshot

The Orthocell share price has lifted more than 38% in the past 12 months and is up 27.78% this year to date.

In contrast, the benchmark S&P/ASX 200 Index (ASX: XJO) has returned nearly 11% in the past year.

Shares in the company reached a 52-week high of 66 cents, while the low was 40.5 cents.

The post Orthocell (ASX:OCC) share price surges 13% on study success appeared first on The Motley Fool Australia.

More reading

• Survey reveals surprising crypto swing as Aussie housing bubble fears grow
• Here’s why the Strike Energy (ASX:STX) share price is surging 13% today
• Up 27% in a month, the Lynas (ASX:LYC) share price just hit another 9-year high. Here’s why
• WAM (ASX:WAM) share price higher on PM Capital fund takeover news
• Why is the Mesoblast (ASX:MSB) share price blasting 10% higher today?

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3Dt7IcI

Crypto assets like Bitcoin (CRYPTO: BTC) and Ethereum (CRPTO: ETH) have been making plenty of headlines of late.

That’s in part because they both notched new all-time highs in November. And in part because crypto adoption is rapidly going mainstream.

Even the Reserve Bank of Australia (RBA) and Treasury are in discussions on launching a Central Bank Digital Currency (CBDC).

Now the latest YouGov research commissioned by crypto wealth platform Dacxi reveals that Australians are increasingly looking to crypto to build wealth, with 4 in 10 saying the Aussie property market is in a bubble.

Crypto investing plans rise on property bubble fears

According to the survey, 30% of Aussie adults believe “crypto will generate more value over the next 10 years than housing”.

As you’d expect, younger respondents were more positive on the outlook for crypto compared to housing than older respondents. 45% of Millennials agreed that crypto was likely to outperform housing in the next decade compared to only 15% of Baby Boomers.

As for people who’ve previously invested in digital assets, 81% said they thought crypto would generate more value than housing over the coming 10 years.

Based on the survey results, 17% of Australians are considering investing in crypto to save for a house deposit, while 56% do so with the intent to build long-term wealth.

Another striking survey result revealed that 29% of Aussies agree that it’s important to include crypto as part of an investment portfolio.

Commenting on the survey results and the markedly different responses between the age groups, Dacxi CEO, Ian Lowe said:

Vanguard has done incredible things for democratising access to traditional assets, but it has a blind spot when it comes to crypto. The next generation is looking for an alternative asset class they can have faith in that will perform well over the long term and that is accessible to younger, less established investors.

2 tokens considered to offer the best 12 month returns

Bitcoin and Ethereum topped the list of cryptos that respondents believe will provide the highest returns over the next 12 months.

According to Lowe:

Bitcoin recently hit another all-time high of US$68,521, then dropped as low as US$53,701 over the following 2 weeks. Picking price peaks and troughs is nearly impossible, even for professional traders. However, the 1 year and 3 year return on Bitcoin is 190.7% and 235.2% respectively, returns that have significantly outperformed even the booming equities market. And other headline cryptocurrencies like Ethereum also continue to perform strongly.

It’s not a surprise then to see that our survey found these 2 coins are considered the most likely to offer the best returns over the next 12 months, with 58% of respondents and 47% respectively.

The post Survey reveals surprising crypto swing as Aussie housing bubble fears grow appeared first on The Motley Fool Australia.

More reading

• Why Cryptocurrency Mining Stocks Were Up Big Today
• Can Bitcoin and other cryptos be used as an inflation hedge?
• Betashares CRYPTO ETF (ASX:CRYP) drops 16% in the past week. What’s next?
• Missed out on Ethereum? Here’s a possible alternative
• Why Ethereum, Dogecoin, and Solana Fell This Morning

The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended Bitcoin and Ethereum. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3EERY7R

Shares in Strike Energy Ltd (ASX: STX) are claiming territory today. The Strike Energy share price is currently trading up around 13% at 17.5 cents a pop.

Stike’s share price has been on the move today. Investors are responding positively to an update on the Walyering-5 well and the miner’s exploration and appraisal activities in its central Perth Basin.

What did Strike announce?

Strike advised it has successfully run in and cemented the 5.5 inch casing for the Walyering-5 well. Moreover, the company has successfully pressure tested the casing string in the well.

The company says the cost of the Walyering-5 well has come in under budget with the drilling performance exceeding expectations.

The total cost estimate for drilling and evaluation of W5 is currently a gross $8.5 million. However, overhead and owners’ costs are not part of this estimate, per the release.

Walyering now presents a low capital expenditure (capex) and fast development opportunity for Strike to monetise the asset on a successful production test scheduled for Q1 2022.

According to Strike Energy, the Walyering project is fast to market. Furthermore, it represents a low capital development opportunity for several reasons.

The first reason is that gas specification is better than pipeline. Further, testing has identified nearly zero impurities in measured gas samples (H2S, nitrogen, CO2). Among other factors, the reservoir pressure measured at 5x the operating pressure of Parmelia Gas Pipeline.

Furthermore, what Strike Energy labels as the “simple profile” of the Walyering gas accumulation means “nominal infrastructure downstream of the wellhead is expected to be required before the gas enters the Parmelia Gas Pipeline, and in turn minimal non-well capital expenditure pre-production.”

Strike will now run a cement bond log and vertical seismic profile before suspending the well. The rig will then be demobilised to the South Erregulla-1 well site. Flow testing of the W5 well is set to occur in Q1 2022 as part of a broader testing campaign.

As such, the company is investigating a concept design of a production system that could support additional resource from 2 wells from the main lobes of the Walyering gas field.

It has already commenced work to identify the location and design of the Walyering-6 well, according to the announcement.

Management commentary

Speaking on the announcement, Strike Energy managing director and CEO Stuart Nicholls said:

The successful application of 3D seismic and corresponding conventional gas accumulation at Walyering has provided the company with a new suite of opportunities for very near term and future gas production in order to both capture the current favourable gas market conditions and to materialise its longer-term vertically integrated downstream strategy.

Nicholls continued:

The Company is currently incorporating the results of Walyering into its development plans and, post a successful flow test in early 2022, will engage with an independent certifier to book reserves and resources at Walyering.

Strike Energy share price snapshot

It’s been a difficult year for Strike Energy shareholders, as its share price has collapsed more than 35% in the past 12 months.

This year to date it is also down nearly 39%. However, it has regained strength in the last month to trade over 9% in the green.   

The post Here’s why the Strike Energy (ASX:STX) share price is surging 13% today appeared first on The Motley Fool Australia.

More reading

• Why Boral, Metcash, Silver Lake, and Strike Energy shares are pushing higher
• Here’s why the Strike Energy (ASX:STX) share price surged 18% today
• Here’s why the Strike Energy (ASX:STX) share price isn’t cooking with gas today
• Why is the Strike Energy (ASX:STX) share price climbing today?

The  author has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/31w3T9V

Shares in rare earth minerals player Lynas Rare Earths Ltd (ASX: LYC) are edging higher today and now trade 4% in the green at $9.29.

Today’s price action signals a 9-year high for the company, having surpassed its former glory levels of $9 a share from 2012. Here’s a closer look.

What’s up with the Lynas share price lately?

It’s been fairly quiet out of Lynas’ corner over the last month or so. Nevertheless, its share price has charged northwards with authority as investors pile in to secure a spot in the company.

As the price of rare earth commodities continues in a cyclical uptrend, this bodes in well for Lynas’ earnings and its share price.

For instance, in its AGM held last week, Lynas gave an upward revision on its forecast for the demand of neodymium-praseodymium (NdPr), an alloy used in numerous tech products and applications, such as electric motors.

The company now sees an annual growth rate of 10% in this division, a 300 basis point uptick from previous estimates.

Underscoring the upgrade to forecasts is the surging demand for electric vehicles, the sales of which increased by 140% during Q1 2021. This upward swing in eclectic mobility has sent the price of Neodymium itself around 68% higher since the beginning of 2021.

Investors are also paying attention to Lynas’ positioning outside of China as a source of rare earths, given that China is the largest producer of this category.

As such, Lynas’ offering lends diversification benefits away from a single region, which could positively impact demand and supply dynamics as well, according to previous analysis.

What else is weighing in?

Aside from the market mechanics driving the Lynas share price, sentiment appears to be overwhelmingly positive on the company right now.

For instance, the team at Sydney investment firm Barrenjoey recently initiated coverage on the stock, rating it overweight with $10.50 valuation.

Barrenjoey likes the outlook for Lynas and reckons its share price has the legs to run further yet. At the time of writing, its price target implies a 13% upside potential, which Lynas is fast encroaching.

Investors are keeping up the pace as well. The volume of Lynas shares traded today is already at 60% of its 4-week average of more than 5 million.

Lynas shareholders have enjoyed an extended run in the green, with the company’s share price soaring more than 120% in that time.

This year to date, it has rallied over 133% and has gained a further 27% in the past month of trading.

The post Up 27% in a month, the Lynas (ASX:LYC) share price just hit another 9-year high. Here’s why appeared first on The Motley Fool Australia.

More reading

• Here’s how EV mania is supercharging growth for Lynas (ASX:LYC)
• These were the best performing ASX 200 shares last week
• 5 best ASX 200 resource shares to hold in November
• Lynas (ASX:LYC) share price tipped for 18% upside
• These were the 5 best performing ASX 200 shares in November

The author has no positions in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3y66LG9

The WAM Capital Limited (ASX: WAM) share price is pushing higher on Wednesday.

In afternoon trade, the investment company’s shares are up 1% to $2.23.

Why is the WAM share price rising?

The catalyst for the rise in the WAM share price today could be news that its potential takeover of PM Capital Asian Opportunities Fund Ltd (ASX: PAF) was given a boost.

WAM is currently battling it out with PM Capital Global Opportunities Fund Ltd (ASX: PGF) for control of the fund.

In September, WAM made an off-market proposal to acquire the PM Capital Asian Opportunities Fund for one WAM Capital share for every 1.99 PAF share owned. Based on the WAM share price at the time, this implied an offer of ~$1.15 per share.

WAM believes this is superior to the offer that the PM Capital Global Opportunities Fund has made.

At the time of the offer, WAM’s Chairman, Geoff Wilson, commented: “WAM’s Offer to acquire 100% of PAF Shares on superior terms to the opposed Scheme provides a meaningful choice for PAF Shareholders and their investments.”

“Following acceptance of WAM’s superior proposal, PAF Shareholders have the option to remain a WAM Shareholder; or utilise WAM’s superior on-market liquidity to exit your position at a premium to net tangible asset (NTA) backing. The Offer allows PAF Shareholders to exit their PAF Shares by acquiring 1 WAM Share for every 1.99 PAF Shares held,” he added.

However, the PM Capital Asian Opportunities Fund’s Board didn’t see things that way and continued to recommend the offer from its Global Opportunities Fund. This led to WAM contacting the Takeovers Panel.

What’s the latest?

The good news for WAM is that its takeover bid was given a boost this week after the Takeovers Panel found PM Capital had breached the Corporations Act.

The Panel found that “holding notices given by PGF, PMC and the Moore Group contravened s671B.”

It also highlighted the acquisition of approximately 3.19% of PAF shares by associated entity Moore Group resulted in contraventions of s606(1), among other things.

Given that this isn’t a good look for a fund manager, WAM will no doubt be hoping this strengthens its offer and weakens PM Capital’s offer when it comes to voting next week. Though, it is worth noting that Paul Moore (and his associated entities) and PM Capital are seeking a review of the initial Panel’s decision.

The post WAM (ASX:WAM) share price higher on PM Capital fund takeover news appeared first on The Motley Fool Australia.

More reading

• You want an ASX share to hold for 4 years? Here are 2!
• Own WAM Capital (ASX:WAM) shares? Here’s what the company has planned for 2022
• Wilson Asset Management (WAM) thinks these 2 top ASX shares are a buy

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3y6hFvF

The Mesoblast Limited (ASX: MSB) share price is shooting higher today despite the company’s silence.

In fact, the market hasn’t heard any price-sensitive news from the biotechnology company in two weeks.

Still, the company’s stock is well and truly in the green today. At the time of writing, the Mesoblast share price is $1.75, 9.69% higher than its previous close.

For context, the S&P/ASX 200 Index (ASX: XJO) is currently up 1.17%. Meanwhile, the All Ordinaries Index (ASX: XAO) has gained 1.29%.

Let’s take a look at the latest news from the company.

What’s going on with the Mesoblast share price?

At its current share price, Mesoblast has now officially recovered from its late-November dip.

The company released its results for the first quarter of financial year 2022 on 24 November.

Within them, it reported a US$2.3 million year-on-year revenue increase, bringing its takings for the quarter up to US$3.6 million.

The company also reduced its cash usage, its research and development expenses, and its manufacturing expenses.

Perhaps unsurprisingly, the market bid the Mesoblast share price higher on the back of its results, sending it to gain 1.7%. However, it tumbled 11.3% over the following 6 sessions.

Between then and now, the company has conducted its annual general meeting and announced findings regarding its Rexlemestrocel-L drug.

On Monday, the company announced the DREAM-HF Phase 3 trial of Rexlemestrocel-L in patients with chronic heart failure and low ejection fraction (HFrEF) found the greatest benefit from Rexlemestrocel-L is in HFrEF patients with diabetes, ischemia, or both.

While the news wasn’t marked as price-sensitive, the Mesoblast share price gained 3.5% on Monday.

Finally, potentially helping Mesoblast along today is the broader healthcare sector’s performance. The S&P/ASX 200 Health Care Index (ASX: XHJ) is currently up 0.6%, with nearly all its members recording gains.

While it’s not as stellar as the broader market’s performance, it’s still good news for the company and its peers.

Yet. despite today’s gains, the Mesoblast share price is still 22% lower than it was at the start of 2021. It’s not all bad though — it’s gained 5% since this time last month.

The post Why is the Mesoblast (ASX:MSB) share price blasting 10% higher today? appeared first on The Motley Fool Australia.

More reading

• These are the 10 most shorted ASX shares
• These are the 10 most shorted ASX shares
• Mesoblast (ASX:MSB) share price crawls higher on Q1 trading update
• These are the 10 most shorted ASX shares
• Mesoblast (ASX:MSB) share price tumbles 8% giving back most of yesterday’s gains

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

from The Motley Fool Australia https://ift.tt/3lIbcBW